HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,348,765 | -16.5% | 61,486 | -21.1% | 0.01% | -18.2% |
| Q2 2023 | $2,811,837 | +95.3% | 77,955 | +106.8% | 0.01% | +83.3% |
| Q1 2023 | $1,439,457 | -13.7% | 37,692 | +28.5% | 0.01% | -14.3% |
| Q4 2022 | $1,668,649 | +65.9% | 29,326 | +15.2% | 0.01% | +40.0% |
| Q3 2022 | $1,006,000 | +947.9% | 25,450 | +1067.4% | 0.01% | – |
| Q2 2022 | $96,000 | +77.8% | 2,180 | +62.1% | 0.00% | – |
| Q1 2022 | $54,000 | -5.3% | 1,345 | -4.3% | 0.00% | – |
| Q4 2021 | $57,000 | +3.6% | 1,406 | +3.8% | 0.00% | – |
| Q3 2021 | $55,000 | -1.8% | 1,355 | +9.7% | 0.00% | – |
| Q2 2021 | $56,000 | +9.8% | 1,235 | 0.0% | 0.00% | – |
| Q1 2021 | $51,000 | +27.5% | 1,235 | +32.8% | 0.00% | – |
| Q4 2020 | $40,000 | – | 930 | +6100.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 15 | -92.5% | 0.00% | – |
| Q4 2014 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |